Chemotherapy in First-line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer

Status: open

A Phase 3, Randomized, Global Trial of Nivolumab and Epacadostat with Platinum Doublet Chemotherapy versus Platinum Doublet Chemotherapy in First-line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer

Treatment for Lung Cancer

Contact Us Or call (251) 445-9834

Description

The purpose of this study is to evaluate the efficacy and safety of the combination of nivolumab plus epacadostat in combination with platinum chemotherapy compared with platinum chemotherapy alone, in participants with treatment-naïve Stage 4 or recurrent non-small cell lung cancer (NSCLC).

Sponsors

This trial is sponsored by Incyte Corporation.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.